Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients
A newly released observational analysis found that 84.4% of cancer patients treated off-label with a compounded combination of Ivermectin and Mebendazole experienced a clinical benefit. The post Ivermectin + Mebendazole: Groundbreaking Stud
Republican Ledger staff · 7:50 AM ET
Our newsroom is writing this report…
A newly released observational analysis found that 84.4% of cancer patients treated off-label with a compounded combination of Ivermectin and Mebendazole experienced a clinical benefit. The post Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients appeared first on Breitbart.
Recommended Stories
Trending nowBarack Obama announces death of ‘cherished’ former first dog Sunny
Former first dog Sunny Obama has died, her longtime master, former President Barack Obama, announced Wednesday. She was 13.
Republican Ledger staff · 8:56 AM ET
PoliticsFederal judge refers George Soros-backed Philadelphia DA Larry Krasner for DOJ probe
WASHINGTON — A Philadelphia federal judge referred the City of Brotherly Love’s George Soros-backed District Attorney Larry Krasner to the Justice Department Tuesday for investigation into whether he violated the law while trying to get a 2
Republican Ledger staff · 8:29 AM ET
Politics'American Idol' Ditches Gavin Newsom's California for Atlanta in Latest Blow to Hollywood Production
The long-running competition series American Idol will be shipping production from Los Angeles to Atlanta for its 25th season. The post ‘American Idol’ Ditches Gavin Newsom’s California for Atlanta in Latest Blow to Hollywood Production app
Republican Ledger staff · 8:21 AM ET
NationNBC reporter, pilot among the victims identified in deadly Los Angeles helicopter crash
Journalist Eliana Moreno and pilot George Marciniw were identified as victims of the NBC4 helicopter crash in Los Angeles' Chatsworth neighborhood.
Republican Ledger staff · 8:17 AM ET
Reader Discussion
0 comments- Loading comments…